Latest Breaking News On - Committee of myovant - Page 1 : comparemela.com

Sumitovant Biopharma to Acquire all Outstanding Shares of Myovant for $27 Per Share in Cash Combination Provides Expertise and Resources to Address Unmet.

United statesSumitomo pharmaMaya frutigerHiroshi nomuraSumitovant biopharmaMark guinanDavid marekUneek mehraMyrtle potterSumitomo mitsui banking corporationJp morgan securitiesCommittee of myovantSumitomo pharma co ltdYork stock exchangeSumitomo pharma groupWomen health